Device Showcase
Download the app!
INSTALL
Evidence Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
  • REFINE YOUR SEARCH:
  • 16All Results
  • Evidence-Based Medicine GuidelinesEvidence-Based Medicine Guidelines
  • EE+ POEM ArchiveEE+ POEM Archive
  • Cochrane AbstractsCochrane Abstracts
Alemtuzumab for multiple sclerosis
16 results
1 - 16
  • CochraneAlemtuzumab for multiple sclerosis New
    • Abstract
    • Reviewer's Conclusions
  • EBMG Alemtuzumab for multiple sclerosis
    • Evidence Summaries
    • References
  • infoPOEMsAlemtuzumab more effective than interferon for multiple sclerosis
    • General
  • Cochranealemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis Edited (no change to conclusions)
    • Abstract
    • Reviewer's Conclusions
  • EBMG Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
    • Evidence Summaries
  • CochraneRituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
    • Abstract
  • CochraneDimethyl fumarate for multiple sclerosis: Cochrane systematic review
    • Abstract
  • CochraneTeriflunomide for multiple sclerosis New search for studies and content updated (conclusions changed)
    • Abstract
  • CochraneTreatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis New
    • Abstract
  • EBMG Multiple sclerosis (MS)
    • Treatment
  • EBMG** Update Information **
    • Latest Update
  • 1 - 16 of 16 records
Renew my subscription

We're glad you have enjoyed Evidence Central! As a thank-you for using our site, here's a discounted rate for renewal or upgrade.

Your free 1 year of online access expired  .

Want to regain access to Evidence Central?

Log in to Evidence Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
A Evidence Central subscription is required to
Already have an account?Log In
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2022 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebooktwitteryoutubeinstagram

6.0-3329